Editorial: Cerebral amyloid angiopathy: from bench to bedside

Hamid R Sohrabi; Steven M Greenberg; Luke Whiley

doi:10.3389/fnins.2024.1370352

Editorial: Cerebral amyloid angiopathy: from bench to bedside

Front Neurosci. 2024 Feb 6:18:1370352. doi: 10.3389/fnins.2024.1370352. eCollection 2024.

Authors

Hamid R Sohrabi^{1

2}, Steven M Greenberg³, Luke Whiley⁴

Affiliations

¹ Centre for Healthy Ageing, Health Future Institute, Murdoch University, Perth, WA, Australia.
² School of Psychology, College of Health and Education, Murdoch University, Perth, WA, Australia.
³ Massachusetts General Hospital and Harvard Medical School, Harvard University, Boston, MA, United States.
⁴ Centre for Computational and Systems Medicine, Murdoch University, Perth, WA, Australia.

No abstract available

Keywords: CAA-related inflammation (CAA-ri); amyloid-related imaging abnormalities (ARIA); cerebral amyloid angiopathy (CAA); fluid biomarkers; iatrogenic CAA (iCAA); peak width of skeletonized mean diffusivity (PSMD); quantitative susceptibility mapping (QSM).

Publication types

Editorial

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.